Newsroom

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it will present important data at this week’s American Heart Association Scientific Sessions in Chicago. AHA 2026 Oral Presentations Date & Time: Saturday, November 7, 3:15 – 4:30 pm CT Session Title: FS.05: Featured Science Session on Novel Lipid Lowering Therapies Location: Learning Studio 2‚ Science and Technology Hall‚ South Hall Title: First-in-Human Trial of a Dual Functional RNAi Mo...

HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) has named Siva Barnwell Adams corporate secretary and chief governance officer, effective Jan. 1, 2027.In her new role, Barnwell Adams will counsel the board of directors and Chevron’s senior management on corporate governance matters, manage the Corporate Governance Department and serve on the Law Function Executive Committee. She succeeds Mary A. Francis, who will retire from Chevron in May 2027 after 25 years with the company.“Siva bri...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 30.10.2026 GAUG LN IE000TGSG3Y5  900,002.00 USD  33,886,121.32   37.651  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 30.10.2026 MSEP.LN IE0009DRFET8 50,002.00 USD 1,422,744.24 28.454  ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to present at the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference in Boston: November 9, 4:00-4:25pm ET Wolfe Research Healthcare Conference in New York City: November 10, 4:00-4:30pm ET Jefferies London Healthcare Conference in Lo...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that its management will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, at 9 a.m. EST. Interested parties can access the live audio webcast of the presentation from the Investor Relations section of the company’s website at www.immunome.com. The w...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 30.10.2026 RDVY LN IE000K5F6EL4 1,325,002.00 USD 33,389,412.25 25.200  ...

NEW YORK--(BUSINESS WIRE)--Enhanced Group (NYSE: ENHA) today announced that various key shareholders, including Apeiron Investment Group Ltd., the family office of Enhanced Group Co-Founder Christian Angermayer, as well as Enhanced Group Co-Founder and CEO Maximilian Martin, have voluntarily agreed to extend the lock-up period on their so far locked shares until May 8, 2027. As a result, the number of existing shares scheduled to be released from contractual lock-up arrangements on November 8,...

LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today kicked off its annual in-store fundraising campaign benefiting Children’s Miracle Network. Throughout November, customers at participating Valvoline Instant Oil Change, Great Canadian Oil Change, and Oil Changers locations can donate to support children and families in their local communities. This year marks Valvoline Inc.’s 17th year supporting Children’s Mi...

NEW YORK--(BUSINESS WIRE)--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, November 9, 2026, at 8:30 AM ET to discuss results for the third quarter 2026 and to provide a business outlook for the remainder of 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnin...